Harbin, China – 11 Sep 2026 – The Heilongjiang Provincial Healthcare Security Administration has published the draft “Heilongjiang Province Medical Insurance Medical Consumables Payment Standards (2026)” for public comment, a province‑wide framework that integrates and maps medical insurance consumables codes and sets reimbursement payment standards – prioritizing the classification, coding and universal generic name management of bone, cartilage and soft‑tissue implant consumables. The consultation window runs from 11 to 16 September 2026.
Policy Milestone
| Item | Detail |
|---|---|
| Issuing Agency | Heilongjiang Provincial Healthcare Security Administration |
| Document | Heilongjiang Province Medical Insurance Medical Consumables Payment Standards (2026) – Draft for Comments |
| Policy Basis | NHSA Notice on Properly Carrying Out Payment Management of Medical Consumables under Basic Medical Insurance (Yi Bao Fa [2023] No. 23) and related documents |
| Core Content | Integrated code mapping for insured medical consumables; establishment of payment standards (detailed schedules in the attachment) |
| Priority Category | Bone, cartilage and soft‑tissue implant consumables – classification & code and universal generic name management |
| Comment Period | 11–16 September 2026 |
| Submission Channel | Email to yyfwglc@163.com; telephone 0451‑88830031 |
Payment Standards Framework
- Standardized Payment Management: The draft is designed to further regulate payment management of medical consumables covered by the province’s medical insurance programs and to improve the efficiency of insurance fund usage.
- Code Integration & Mapping: The Administration will consolidate and map medical insurance consumables codes and set corresponding payment standards – aligning provincial reimbursement practice with national coding and universal generic name requirements.
- Implant Focus: The notice specifically invokes management requirements for bone, cartilage and soft‑tissue implant consumables – a high‑value category long targeted by national and regional procurement and price‑governance efforts.
- Detailed Standards: Category‑level and product‑level payment standard values are set out in the draft’s attachment and were not disclosed in the public notice itself.
Public Consultation Requirements
- Timeline: Comments accepted from 11 September through 16 September 2026.
- Format: Opinions and suggestions – with supporting reasons – must be submitted by email to the Provincial Healthcare Security Administration.
- Authentication: Feedback materials must bear the official seal of the submitting organization or the authentic personal signature of an individual, and must include contact details; anonymous emails will not be accepted.
Market Impact & Outlook
- Reimbursement Ceiling Signal: Codified provincial payment standards effectively set reimbursement reference ceilings for insured consumables in Heilongjiang, with hospitals and patients bearing costs above the standard – pressuring suppliers to align pricing accordingly.
- Implant‑Category Focus: By foregrounding bone, cartilage and soft‑tissue implants, the draft extends the national playbook of coding uniformity plus payment standard governance to one of the highest‑spending consumable segments.
- National Alignment: Anchored in Yi Bao Fa [2023] No. 23, the provincial framework keeps Heilongjiang synchronized with the NHSA’s push for standardized consumables payment management nationwide, reducing cross‑province reimbursement arbitrage.
- Short Feedback Window: The six‑day consultation period suggests the Administration aims to finalize and implement the 2026 standards on a tight cycle ahead of the new year.
- Next Steps: Final payment standard values, effective date and implementation mechanics will depend on the finalized document following the consultation – details not yet disclosed.
Forward‑Looking Statements
This brief contains forward‑looking statements regarding the finalization and implementation of the Heilongjiang Province Medical Insurance Medical Consumables Payment Standards (2026). Actual outcomes may differ due to risks including public feedback, adjustments to draft standards, national policy changes and provincial implementation timelines. The draft remains subject to revision and does not constitute final policy.-China Health Reform Pulse
Policy Source: https://ybj.hlj.gov.cn/ybj/c105387/202609/c00_31974724.shtml